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ABSTRACT
The auxiliary factor of U2 small nuclear RNA (U2AF)
is a heterodimer consisting of 65- and 35-kD proteins
that bind the polypyrimidine tract (PPT) and AG dinu-
cleotides at the 3′ splice site (3′ss). The gene encod-
ing U2AF35 (U2AF1) is alternatively spliced, giving
rise to two isoforms U2AF35a and U2AF35b. Here, we
knocked down U2AF35 and each isoform and char-
acterized transcriptomes of HEK293 cells with vary-
ing U2AF35/U2AF65 and U2AF35a/b ratios. Deple-
tion of both isoforms preferentially modified alter-
native RNA processing events without widespread
failure to recognize 3′ss or constitutive exons. Over
a third of differentially used exons were terminal,
resulting largely from the use of known alternative
polyadenylation (APA) sites. Intronic APA sites ac-
tivated in depleted cultures were mostly proximal
whereas tandem 3′UTR APA was biased toward distal
sites. Exons upregulated in depleted cells were pre-
ceded by longer AG exclusion zones and PPTs than
downregulated or control exons and were largely ac-
tivated by PUF60 and repressed by CAPER . The
U2AF(35) repression and activation was associated
with a significant interchange in the average prob-
abilities to form single-stranded RNA in the opti-
mal PPT and branch site locations and sequences
further upstream. Although most differentially used
exons were responsive to both U2AF subunits and
their inclusion correlated with U2AF levels, a small
number of transcripts exhibited distinct responses
to U2AF35a and U2AF35b, supporting the existence
of isoform-specific interactions. These results pro-
vide new insights into function of U2AF and U2AF35
in alternative RNA processing.
INTRODUCTION
Eukaryotic genes contain intervening sequences or introns
that are removed from mRNA precursors by a large and
highly dynamic RNA–protein complex, termed the spliceo-
some (1). The spliceosome consists of small nuclear ribonu-
cleoproteins (snRNPs), including the U1, U2, U4/U5/U6
of the major U2 spliceosome and the U11, U12, U4atac /
U6atac/U5 of the less abundant U12 spliceosome, and a
large number of non-snRNP proteins (1). Spliceosomes as-
semble on each intron in an ordered manner, starting with
recognition of the 5′ splice site (5′ss) by U1 snRNP or the
3′ss by theU2 pathway (2), which involves binding of theU2
auxiliary factor (U2AF) to the 3′ss region to facilitate U2
snRNP recruitment to the branch point (BP) (3,4). U2AF is
a stable heterodimer composed of aU2AF2-encoded 65-kD
subunit (U2AF65), which contacts the polypyrimidine tract
(PPT), and a U2AF1-encoded 35-kD subunit (U2AF35).
U2AF35 interacts with almost invariant AG dinucleotides
at 3′ss and stabilizes U2AF65 binding to RNA (5–8).
The U2AF1 gene is alternatively spliced, giving rise to
conserved mRNA isoforms termed U2AF1a, U2AF1b and
U2AF1c (9). In mice, U2AF1a is more abundant than
U2AF1b and contains a highly conserved 67-bp exon 3 in
the mRNA whereas U2AF1b incorporates exon Ab of the
same size (9). The U2AF1c isoform includes both exons
that introduce a premature termination codon (PTC) in the
mRNA, which is targeted by RNA surveillance (9). Both
U2AF35a and U2AF35b contain a central U2AF65 recog-
nition domain of the UHM (U2AF homology motif) type
flanked by two C3H-type zinc finger (ZF) domains and a
C-terminal arginine/serine-rich (RS) region (10–13). Both
U2AF35a and U2AF35b interact with U2AF65 and could
stimulate its binding to a PPT (9). During evolution, the
two U2AF35 proteins have been under high selection pres-
sure, suggesting that they may play specific functions in ver-
tebrates and plants (9,14,15), but their putative functional
differences in 3′ss selection are not known.
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Although U2AF35 is essential for viability of both yeast
and higher eukaryotes (16–19), the 3′ss AG was found to
be dispensable for the in vitro splicing of pre-mRNAs with
strong PPTs (20). Binding of U2AF65 and U2AF35 to
weak 3′ss was promoted by splicing activators under splic-
ing conditions (21,22), however, several splicing events as-
sumed to depend critically onU2AF35 did not show any de-
fect under conditions of limited U2AF35 availability in vivo
(14,23) and some alternative 3′ss responsive to U2AF35 de-
pletion were intrinsically stronger than their nonresponsive
counterparts (24). Thus, the distinction between U2AF35-
dependent and -independent introns has remained obscure.
In addition, overexpression of U2AF65 and depletion of
U2AF35 resulted in activation of the same cryptic 3′ss, sug-
gesting that their balance is important for 3′ss selection (24).
However, global RNA processing changes in response to
U2AF35 depletion or varying ratios of U2AF35/U2AF65
have not been examined.
In this study, we have characterized the transcriptome of
human embryonic kidney (HEK) 293 cells lackingU2AF35
and each U2AF35 isoform.
MATERIALS AND METHODS
Cell cultures, transfections and library preparations
HEK293 cells were grown under standard conditions in
DMEM supplemented with 10% (v/v) bovine calf serum
(Life Technologies). For depletion experiments (Supple-
mentary Figure S1), the cells were treated with small inter-
fering RNAs (siRNAs) or splice-switching oligonucleotides
(SSOs) targeting splice sites of mutually exclusive U2AF1
exons 24 h after seeding. Transfections were carried out
in 6- or 12-well plates using jetPRIME (Polyplus) accord-
ing tomanufacturer’s recommendations. The cells were har-
vested after 24 and 48 h or received the second hit after 48 h
when splitting the cells into new plates. The remaining cul-
tures were harvested 24 and 48 h after the second hit. For
RNA sequencing (RNA-Seq), total RNA was extracted us-
ing RNeasy Plus (Qiagen) from cells harvested 72 h after
the first hit. The NEBNext poly(A) mRNA magnetic iso-
lation module (E7490L) and the Human/mouse/rat Ribo-
ZeroTM rRNA Removal Kit (Cambio/Epicentre) for RNA
were employed according to manufacturers’ recommenda-
tions. The libraries were prepared using theNEBNext R©Ul-
tra DNA Library Prep Kit for Illumina R© (E7370L), size-
selected and multiplexed before paired-end sequencing on
the HiSeq 2500 Ultra-High-Throughput Sequencing Sys-
tem (Illumina).
siRNAs to downregulate the remaining proteins were as
previously described (24 and references therein); the siRNA
duplex to heterogeneous nuclear ribonucleoprotein C (hn-
RNP C) was reported earlier (25).
Detection of spliced products
Total RNA was transcribed using the Moloney murine
leukemia virus reverse transcriptase (Promega) and
oligo(dT) primers according to the manufacturer’s rec-
ommendations. Alternatively spliced U2AF35 exons
were visualized by complete HinfI digests of amplified
polymerase chain reaction (PCR) products, as described
previously (9). Signal intensities of amplified fragments
were measured as described (24).
Immunoblotting
Western blot analyses were carried out as described (24)
using antibodies against U2AF35 (10334–1-AP, Protein
Tech Group), U2AF65 (U4758, Sigma), actin (ab37063,
Abcam), tubulin (ab56676, Abcam) and CAPER (PA5–
31103, Thermo Fisher Scientific). AntiXpress antibodies
were purchased from LifeTechnologies (R910–25). Anti-
bodies against PUF60, hnRNPC and hnRNP I (PTB) were
a generous gift of Adrian Krainer, Gideon Dreyfuss and
Christopher Smith, respectively.
RNA-Seq analysis
Apart from the knockdown of U2AF35 and its isoforms
(Supplementary Table S1), we analyzed RNA-Seq data of
previously published knockdown experiments with 11 pro-
teins: heterogenous nuclear ribonucleoprotein (hnRNP) C
(Illumina HiSeq 2000) (25), hnRNPA1, hnRNPA2B1, hn-
RNPH1, hnRNPF, hnRNPM, hnRNPU (IlluminaGAII)
(26),HOXA1 (IlluminaHiSeq 2000) (27), AFF2,AFF3 and
AFF4 (Illumina GAIIx) (28). The raw FASTQ data were
aligned against the human genome and transcriptome ref-
erence using TopHat (v. 2.0.9) (29) and Bowtie (v. 2.1.0) (30)
using default stringencies and parameters, except for mod-
ification of the UCSC reference (hg19) (31) by introduc-
ing the U2AF1 isoform s, which lacks exons Ab and 3. Se-
quences recognized as originating frommtRNA, rRNAand
tRNA were subsequently removed. Analysis of differential
exon usage was performed using DEXSeq (1.12.1) (32) and
MISO (mixture-of-isoforms) (26). DEXSeq-detected exons
were selected based on statistical significance of differen-
tial usage (q < 0.05). Unlike DEXSeq, MISO (v. 0.4.9;
hg19) (26) computes percentage of spliced in (psi, ) splice
junction-spanning reads and examines their significance us-
ing Bayesian factors. The filtering cut-offs were set to de-
fault parameters, on the basis of difference and event sig-
nificance ( > 0.2 and K > 10). Statistically significant
events were individually verified in genome browsers to ex-
clude false positives as a result of misannotated transcripts,
low expression, overlapping transcripts and apparent mis-
classifications.
Differential gene and isoform expression between sample
sets was analyzed with Cufflinks (v. 2.1.1) (33), which nor-
malizes the reads using a fragments per kilobase of exon
model per million reads (FPKM) measure. Gene and iso-
form expression assessment was aided by the transcriptome
reference (hg19, UCSC) with no novel transcript discovery
and was followed by CummeRbund (v. 2.2.0) (33) analysis
of differential gene and isoform expression (in R environ-
ment; v. 3.0.2). Selection of significantly differentially ex-
pressed genes was made on the basis of FDR-adjusted P-
values (q< 0.05). RNA-Seq data for U2AF35 depletion ex-
periments are available at ArrayExpress under the accession
number E-MTAB-2682. Finally, gene- and exon-level func-
tional enrichment analyses of differentially expressed events
were performed using DAVID (34,35).
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Validation of U2AF35-dependent events
RNAwas extracted using TRI reagent, treated with DNase
I (LifeTechnologies) and reverse-transcribed as described
above. Target transcripts were chosen based on P- and
FPKM-values that are shown in full in Supplementary Ta-
bles S2 and S3, respectively. PCR primers (Supplementary
Table S4) were designed to amplify two or more isoforms
with different sizes. Exogeneous transcripts were amplified
using RT-PCR with vector primers PL3 and PL4 (36) or
their combinations with transcript-specific primers.
Plasmid constructs
Splicing reporter minigenes were cloned into pCR3.1 (In-
vitrogen) using primers shown in Supplementary Table S4.
IgM minigenes were a generous gift of Martha Peterson,
University of Kentucky. Plasmid DNA was extracted us-
ing Wizard R© Plus SV Minipreps (Promega). Expression
constructs of U2AF35 isoforms were described previously
(24). PUF60 was subcloned into pCI-neo (Promega) with
the Xpress tag at the N terminus, employing the pET28a-
PUF60-His construct (24) as a template. All constructs were
sequenced prior to transfections to exclude undesired mu-
tations.
Sequence features of U2AF(35)-dependent exons and introns
Sequences individually validated in genome browsers were
examined using algorithms that predict both traditional
and auxiliary splice-site recognition motifs. Intrinsic splice-
site strength was computed using both maximum entropy
and frequency matrix scores (37–40). Prediction of BPs,
PPTs and AG exclusion zones (AGEZs) was carried out
using a support vector machine (SVM) algorithm (41). De
novo motif discovery, motif enrichment and motif location
analyses were performed using the MEME suite of pro-
grammes (42) with sequences flanking differentially used
3′ss, 5′ss and internal exons as the input.
Measurements of single-strandedness across 3′ss
We computed the PU (probability of unpaired) values for
all substrings of high-confidence upregulated and downreg-
ulated sequences in their natural context, extending input
sequences by 30 nt in each direction. The PU values em-
ploy the equilibrium partition function of RNAfold (43)
and were as defined previously (44). Input sequences were
fixed relative to the position of upregulated and downregu-
lated 3′ss. Their PU values were averaged for each intron po-
sition. The means were compared by the Wilcoxon–Mann–
Whitney test. Delta PU values are defined here as the dif-
ference between mean PU values of upregulated and down-
regulated exons at the indicated positions.
RESULTS
Identification of U2AF(35)-dependent exons
We knocked down U2AF35 and each alternatively spliced
U2AF35 isoform in HEK293 cells (Figure 1A and B) and
examined genome-wide exon/transcript usage by RNA-
Seq. We achieved ∼90% depletion with siRNAs targeting
both isoforms and a reversal in the relative abundance of
U2AF35a and U2AF35b using isoform-specific siRNAs,
with a maximum at 72 and 96 h post-transfection (Fig-
ure 1C and Supplementary Figure S1). In addition to siR-
NAs, we employed SSOs targeting 3′ splice sites of alter-
natively spliced U2AF1 exons, resulting in a less robust
and more delayed response in knockdown levels (Supple-
mentary Figure S1). Using the Illumina HiSeq 2500 plat-
form, we obtained a total of 546 390 339 reads mapped to
the annotated human transcriptome and genome, averaging
to 68M per RNA sample (Supplementary Table S1). The
fraction of U2AF1 mRNAs ranged between ∼0.001% for
depleted samples and ∼0.01% for controls, with isoform-
specific knockdowns giving intermediate levels. The range
of U2AF1/U2AF2 ratios varied between 0.1 and 2.3 (Fig-
ure 1D and E). Surprisingly, the U2AF1 depletion was as-
sociated with a 2-fold increase of each alternatively spliced
U2AF2 isoform (Figure 1F). The U2AF1a-specific deple-
tion led to a lower overall U2AF1 expression than the
U2AF1b knockdown while expression of isoforms recog-
nized by RNA surveillance remained low (Figure 1E). The
relative abundance of U2AF1b slightly increased in cells
treated with siRNAs targeting both isoforms compared to
untreated cells (Figure 1E and G).
AsU2AF35 contacts the 3′ss AGdinucleotide as a part of
complexes assembled ad hoc on each intron (5–7), we used
DEXSeq and MISO algorithms to identify exons differen-
tially used in depleted cells. DEXSeq is based on general-
ized linear models and relies on biological controls to iden-
tify differential exon usage (32), whereas MISO employs a
Bayesian approach and splice junction-spanning reads to
detect specific alternative splicing events (26). Altogether,
DEXSeq identified a total of 484 upregulated and 575
downregulated exons in siRNA U2AF35ab-depleted cul-
tures (termed ab-), with no bias toward either (P> 0.05, bi-
nomial test), whereas the number of MISO-detected events
was ∼60% higher (Supplementary Table S2 and data not
shown). Gene-level expression analyses with Cufflinks (33)
revealed 1507 upregulated and 2011 downregulated genes
(Supplementary Table S3). Overlap of genes with differen-
tially used exons and Cufflinks was highly significant (Fig-
ure 1H), suggesting that these exonsmay contribute to over-
all gene expression alterations observed in depleted cultures.
Characterization of global alternative polyadenylation
changes induced by U2AF35 depletion
Among differentially used exons, start and terminal exons
were more frequent than expected while internal exons were
significantly more common among downregulated than up-
regulated events (Figure 2A). We observed a similar bias of
start/end exons for publishedRNA-Seq data of cell cultures
depleted of other RNA-binding proteins, including hnRNP
C, a U2AF65 competitor (25), but not for cells depleted of
a DNA-binding factor (Supplementary Table S5). Almost a
half of differentially used exons were represented more than
once per transcript, consistent with the presence of multi-
exon segments upregulated or downregulated in depleted
cells (Figure 2B). Browser verification of individual events
revealed that activation or repression of terminal exons was
largely due to the altered usage of previously annotated
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Figure 1. Genome-wide identification of U2AF(35)-dependent exons. (A) Alternative splicing of U2AF1 and location of SSOs. Exons are shown as boxes,
introns as horizontal lines, SSOs as black rectangles across 3′ss and spliced products (a, b, c, s) as dotted lines. (B) Nucleotide (upper panel) and amino acid
(lower panel) sequences of alternatively splicedU2AF1 exons. Amino acids are numbered at the bottom. (C)HinfI digested RT-PCR products showing the
relative abundance ofU2AF1 isoforms in depleted samples (upper panel) and immunoblot with antibodies against U2AF35 and tubulin (lower panels). ab-,
depletion of both isoforms using siRNA U2AF35ab (30 nM); a-, depletion of U2AF35a (60 nM); b-, depletion of U2AF35b (60 nM); a-b-, depletion of
U2AF35 using equimolar mixtures of isoform-specific siRNAs; siRNAs were as described (14,23). Ctr, a scrambled control. (D) Normalized expression of
U2AF1 and U2AF2 genes in depleted cultures and controls. FPKM, fragments per kilobase of exon model per million reads. Error bars in panels D–F are
95% confidence intervals. U2AF1/U2AF2 ratios in ab-, a-, b- and control cultures were 0.09, 0.43, 1.47 and 2.25, respectively. (E) Normalized expression
of U2AF1 isoforms. (F) Normalized expression of U2AF2 isoforms. Extra amino acids included in U2AF65 as a result of alternative GC 5′ss usage are in
parentheses. (G) A genome browser view of exon Ab- and 3-containing isoforms in depleted cells (ab-) and controls (ctr). Exons are numbered at the top
and corresponding isoforms are shown at the bottom. Browser views are in the native gene orientation throughout; the 5′>3′ transcriptional orientation
is denoted by the > sign. (H) Significant sharing of genes identified by DEXSeq (exon-level) and Cufflinks (gene-level) as differentially expressed in ab-
cultures versus controls.
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Figure 2. Characterization of global changes in APA induced by U2AF35 depletion. (A) Distribution of start, internal and terminal exons upregulated
and downregulated in cells depleted of U2AF35. P-value was derived from a  2-test for the 3×2 contingency table. P-value for the first exons versus the
pool of internal and terminal exons was <10−7. (B) A high proportion of transcripts with ≥2 differentially expressed exons. (C-E) APA site usage in the
indicated APA categories. Number of proximal and distal APA sites altered in depleted cells is shown above arrows that indicate shifts in APA site usage.
APAP, APAD, proximal and distal polyadenylation sites. Upregulated and downregulated exons are indicated by red and green rectangles throughout.
Each category is schematically shown at the top; yellow rectangles are 3′UTRs, blue boxes are constitutive exons, red and pink boxes are alternative exons.
Splicing is denoted by dotted lines. (F) Frequency distribution of APA categories altered in ab- cells. (G) Breakdown of start, internal and terminal exons
for Cufflinks-positive genes. APA/5′ss, altered APA or 5′ss of the first intron in ab- cells; ATI, annotated alternative transcription initiation sites altered
in ab- cultures. P-value was computed as in panel A. (H) Validation of intronic/alternative 3′ss APA site usage in two plant homology domain-encoding
genes shown in panels D and E. PCR primers are in Supplementary Table S4. (I) Control of mouse intronic APA site usage by humanU2AF35. Schematics
of the mouse IgM minigene with APA sites giving rise to membrane (APAD) and soluble (APAP) immunoglobulins M (upper panel). Del, deletion of the
RNA polymerase II (polII) pausing site (100). The lower panel shows RNA products of the wild-type and deletion-containing IgM minigenes transfected
into HEK293 cells individually depleted of each U2AF subunit. Final concentration of U2AF65 siRNA was 40 nM. Immunoblot is to the right.
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alternative polyadenylation (APA) sites (45), with intronic
APA sites as the most common APA category (Figure 2C–
F and Supplementary Table S6). Categorization of 155APA
sites individually confirmed in a genome browser as affected
by U2AF(35) depletion and verified against APA reposi-
tories revealed that while intron-proximal and -distal APA
sites were about equally represented when APA was asso-
ciated with alternative 3′ss, intronic APA sites promoted in
ab- cultures were largely proximal whereas tandem 3′UTR
APA sites were biased toward distal sites (Figure 2C–E).
Unexpectedly, breakdown of 211 DEXSeq-positive exons
in genes that were either upregulated or downregulated in
depleted cultures (i.e. Cufflinks-positive) showed preferen-
tial involvement of the first exons while terminal and in-
ternal exons were about equally represented (Figure 2G).
Their individual browser inspection revealed that the excess
was attributable to APA and 5′ss of the first introns while
altered usage of annotated alternative transcription initia-
tion sites was rare, further supporting a prominent impact
of U2AF35 depletion on APA.
Together, these data indicated that APAwas amajor con-
tributor to the differential exon usage in depleted cells and
revealed APA category-dependent shifts of proximal and
distal APA sites conferred by a lack of U2AF(35) and/or
an increase of U2AF65. They also suggested that a simple
distribution of differentially used start, internal and end ex-
ons in RNA-Seq depletion experiments could be indicative
of the relative importance of a depleted factor for eachRNA
processing step.
A high validation rate of DEXSeq-detected alternative RNA
processing events
Extensive experimental validation of 82 high-confidence
DEXSeq-detected events from the same and independent
depletion experiments with the same cell line confirmed 76
exons (Supplementary Table S4, Figure S2), including alter-
native 3′ss APA inPHF14 and intronic APA inPHF19 (Fig-
ure 2H). Apart from endogenous RNAs, altered exon inclu-
sion as a result of U2AF(35) depletion was found also for
exogenous transcripts (see below), including murine IgM
transcripts without the RNA polymerase II (polII) pause
site located between proximal and distal APA sites (Fig-
ure 2I). As browser verification of MISO-detected events
showed a higher false positivity than for DEXSeq (data
not shown), their systematic validation was not carried out.
However, a high stringency of default DEXSeq settings and
a high sensitivity ofMISOmay provide a higher accuracy in
identifying genuine alternative RNA processing events af-
fected by U2AF35 depletion, complementing each other.
U2AF35 dependency can be explained largely by a lack of the
U2AF heterodimer
Apart from altered exon usage seen only in ab- cultures,
most transcripts showed a gradient in RNA processing de-
fects, with a hierarchy ab- > a- > b- > controls, mirroring
total levels of U2AF35 or U2AF (cf. Supplementary Figure
S2A and Figure 1C–E). Individual depletion of each U2AF
subunit in HEK293 cells showed that U2AF65 depletion,
which reduces U2AF35 levels (14) (Figure 2I), shifted us-
age of most exons in the same direction as U2AF35 de-
pletion (Supplementary Figure S2B). In MAPK8IP3 tran-
scripts, however, depletion of U2AF35 promoted inclusion
of an 18-nt exon; in contrast, U2AF65 depletion and de-
pletion of U2AF35a failed to activate this exon and led
to skipping of the preceding 12-nt exon instead. To under-
stand this phenomenon, we examined these pre-mRNAs in
a dose-dependent transfection experiment shown in Supple-
mentary Figure S3A. Interestingly, U2AF65 depletion in-
creased the relative abundance ofU2AF35b, suggesting that
skipping of the 12-ntMAPK8IP3 exon in a- and U2AF65-
cells was due to the excess of U2AF35b. As U2AF65 de-
pletion reduced U2AF65 more than U2AF35, potentially
limiting the amount of the available heterodimer, we esti-
mated residual levels of U2AF in each sample by measur-
ing signal intensity from immunoblots from the same trans-
fection (Supplementary Figure S3A). U2AF levels corre-
lated significantly with the usage of most exons, particularly
with those excluded from pre-mRNAs in depleted cells. In
contrast, many exons upregulated inU2AF35 depleted cells
were not activated in cells lackingU2AF65, and several very
small exons, including a 12-nt MAPK8IP3 exon, did not
correlate with U2AF (Supplementary Figure S3B–D and
below). Thus, most but not all differential exon usage in-
duced byU2AF35 depletion could be attributed to a lack of
theU2AF heterodimer and sequences of these exons should
therefore reveal binding signatures of both U2AF subunits.
Identification of 3′ splice sites altered by U2AF35 depletion
Combined MISO (26) and DEXSeq (32) analyses identi-
fied a total of 231 differentially used alternative 3′ss pairs.
Their individual inspection in genome browsers confirmed
138 pairs of 3′ss, with 93 intron-proximal sites promoted
and 45 repressed in ab- cultures (Supplementary Table S7).
Only 51/138 sites (37%) promoted in ab- cultures were in-
trinsically stronger than their competing counterparts (bi-
nomial test, two-tail P = 0.003; Supplementary Table S9).
We also observed a significant lack of canonical cytosine at
position −3 and guanine at position +1 relative to upreg-
ulated proximal 3′ss (Supplementary Figure S4A and B).
Both positions contribute substantially to the 3′ss strength
(37).
Since over a third of APA sites altered in depleted cells
was associated with annotated alternative 3′ss usage (Fig-
ure 2E and 2F, Supplementary Table S6), we tested if their
intrinsic strength contributes to APA selection. Analysis of
browser-verified 57 pairs of alternative APA 3′ss showed
that unlike alternative 3′ss not associated with APA, intrin-
sically weaker sites were not preferred (28 stronger versus
29 weaker in ab- cultures). Likewise, we observed no en-
richment of weaker sites when comparing proximal upreg-
ulated and downregulated APA 3′ss with APA 3′ss of ter-
minal exons. Although the number of APA-associated al-
ternative 3′ss was smaller than the number of non-APA 3′ss
pairs, this result is consistent with an additional function of
U2AF in APA control that is independent of interactions
with alternative 3′ss of internal exons.
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U2AF(35) depletion can influence 5′ splice-site usage
U2AF35 contacts 3′ss AG (5–7), but we identified at least
32 alternative 5′ss pairs influenced by U2AF35 depletion.
Eleven of them were tested using RT-PCR and 10 were con-
firmed (Supplementary Tables S4 and S8; Figure S5A–G).
Over a third of these 5′ss (n = 11) were located in the first
introns. As for 3′ss, proximal (26 versus 6) and weaker (19
versus 13) 5′ss were activated more often in depleted cul-
tures than their distal and stronger counterparts. Activa-
tion of cryptic 3′ss was occasionally accompanied by cryp-
tic 5′ss activation of the same exon (Supplementary Fig-
ure S5H). Because intronic APA sites compete with up-
stream 5′ ss (46), we also determined the intrinsic strength
of the first 5′ss upstream of 67 intronic APA sites affected by
U2AF35 depletion. Their average scores tended to be lower
(P= 0.12; Supplementary Table S9) than those of authentic
counterparts of aberrant 5′ss, which were used as controls
(40).
U2AF35 depletion activates exons with longer AGEZs and
PPTs
Examination of 204 browser-verified internal exons that
excluded multiple-exon regions associated with APA sites
revealed that U2AF35 depletion promoted both exon in-
clusion and skipping as well as intron splicing and, spo-
radically, intronization within large exons (Supplementary
Figure S6A and B). Interestingly, exon activation in de-
pleted cells often occurred in weak, incompletely removed
introns (Supplementary Figure S6C). U2AF(35)-sensitive
exons were largely alternatively spliced and had sequence
features typical of alternative exons (Supplementary Figure
S7 and Table S10). Importantly, upregulated exons had a
significantly longer AGEZ than downregulated or control
exons (Figure 3A), but did not show a comparable decrease
of other purine dinucleotides upstream of 3′ss (Supplemen-
tary Figure S8A). The AGEZ length correlated with the ex-
pression change of upregulated but not downregulated ex-
ons (Figure 3B and C). Upregulated exons had also longer
PPTs for the best predicted BP although the associated P-
values were lower than for the AGEZ (Figure 3D). The PPT
length also correlated with the change in usage of upregu-
lated exons (Figure 3E and F). A specific lack of AGs and
longer AGEZs/PPTs was found also upstream of alterna-
tive 3′ss upregulated in ab- cultures (insets in Figure 3A
and D and Supplementary Figure S8B) and this tendency
was observed also for as few as 57 alternative 3′ss leading to
APA (Supplementary Figure S9, Figure 2E).
Interestingly, the lack of AGs upstream of upregulated
exons was associated with adenine depletion between posi-
tion−17 and −38, which approximately corresponds to the
optimal BP location (20,47), whereas guanine depletion was
more widely distributed (Supplementary Figure S10A and
B). Instead, upregulated exons showed enrichment for ade-
nine at positions−3 to−9 while uridine tended to show the
opposite, with enrichment between −17 and −38 and de-
pletion closer to the 3′ss. Conversely, downregulated exons
showed adenine enrichment in the optimal BP region, par-
ticularly in smaller exons (Supplementary Figure S10C–E),
and uridine enrichment closer to 3′ss. We also searched for
additional known and unknown motifs in sequences flank-
ing U2AF(35)-sensitive junctions using theMEME suite of
programs (42), however, no significant hits were found.
We conclude that 3′ss upregulated in ab- cells have longer
AGEZs/PPTs, adenine depletion in the optimal BP loca-
tion and enrichment closer to 3′ss, with uridines showing
the opposite pattern. This arrangement moves PPTs fur-
ther upstream of upregulated exons as compared to their
downregulated counterparts. The observed widespread re-
pression by U2AF(35) could thus reflect a lack of AG din-
ucleotides upstream of 3′ss, which are generally repressive
when located downstream of BPs (20,48,49), and/or longer,
more upstream PPTs, which may bind exon-repressive PPT-
binding proteins (25,50). Because these sequence character-
istics are likely to influence secondary structure formation
across 3′ss, this group of exons should provide a powerful
tool to study regulation of 3′ss by RNA-binding proteins
and RNA folding.
Exons repressed by U2AF(35) are stimulated by PUF60 and
inhibited by CAPER
To examine the role of U2AF-related proteins in usage of
U2AF-dependent exons, we measured inclusion of 44 exons
in HEK293 cells depleted of PUF60, CAPER (RBM39),
CAPER (RBM23) and two other Y-binding proteins (Fig-
ure 3G). PUF60 and U2AF were individually capable of
protecting the 3′ss AG in footprinting experiments (51),
but the exact function of CAPER/ in recognition of
3′ss or U2AF-dependent exons is unknown. We also de-
pleted hnRNP A1, which allows U2AF to discriminate be-
tween pyrimidine-rich RNA sequences followed or not by
a 3′ splice-site AG (52), and DEK, which facilitates the
U2AF35-AG interaction and prevents binding of U2AF65
to pyrimidine tracts not followed by AG (53) (data not
shown). Remarkably, the majority of exons upregulated in
cells depleted of U2AF35 were downregulated in cells de-
pleted of PUF60 (Figure 3H and Supplementary Figure
S11). In contrast, CAPER, and to a lesser degree PTB,
showed synergism with U2AF(35) for this group of ex-
ons (Figure 3H). A significant directionality of hnRNP C,
DEK and hnRNP A1 could not be established with this
sample size (Figure 3H and data not shown). To confirm
that PUF60 stimulates exons repressed by U2AF, we mea-
sured exon inclusion of a minigene reporter transfected
into HEK293 cells lacking or overexpressing PUF60 (Fig-
ure 3I). We found that cells lacking PUF60 showed in-
creased skipping of this exon, whereas the PUF60 over-
expression increased its inclusion in the mRNA. Thus,
U2AF(35)-induced exon usage was predictive of responses
to other Y-binding proteins, revealing the connection be-
tween antagonism and synergism of U2AF-related proteins
and characteristic 3′ss organization described above.
Unpaired regions upstream of U2AF(35)-activated and -
repressed exons
Because characteristic changes in nucleotide frequencies
upstream of U2AF(35)-dependent exons (Supplementary
Figure S10) are likely to affect formation ofRNA secondary
structure, which can influence 3′ss utilization (54,55), we
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Figure 3. Structural and functional characterization of U2AF(35)-dependent 3′ss. (A, D) AGEZ (A) and PPT (D) length of alternative 3′ss (inset) and
internal exons affected by U2AF35 depletion. Columns show means, error bars denote SDs. The number of each event is in the legend to Supplementary
Figure S8. PPT length was computed for BPs with the highest SVM scores (41). P-values were derived from t-tests; ****P< 0.00005; **P< 0.005. AGEZ
and PPT length correlated with the expression change of upregulated (B, E) but not downregulated (C, F) exons; r, Pearson correlation coefficient. (G)
Immunoblots prepared from lysates from HEK293 cells depleted of poly(Y)-binding proteins (indicated at the top). Antibodies are shown at the bottom
or to the right. (H) Functional antagonism and synergism of Y-binding proteins and U2AF. Exon inclusion levels of each transcript are in Supplementary
Figure S11; RT-PCRprimers are in Supplementary Table S4. Residual protein levels (RPL) were estimated from immunoblots shown in panel G. TheY-axis
is on a log10 scale. Average changes between inclusion levels of upregulated and downregulated exons were compared by the Wilcoxon-Mann-Whitney test
(*P < 0.05; **P < 0.005; ***P < 0.0005; ****P < 0.00005; NS: not significant; -: not tested). (I) Opposite effects of PUF60 depletion and overexpression
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at the top; alternative exon is denoted by a white rectangle. Exogeneous RNA products were amplified by primers PL3 and PL4. Error bars are SDs of
duplicate transfections. (J) Positional differences in unpaired probabilities upstream of U2AF(35)-activated and repressed exons. Positive delta PU values
signify a higher average single-strandedness of upregulated exons in the optimal BP location and further upstream as compared to downregulated exons
whereas negative values reveal their tendency to engage in local base-pairing interactions closer to 3′ss. Stars denote positions with P-values <0.05.
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computed position-specific probabilities of RNA single-
strandedness (44) for high-confidence upregulated and
downregulated internal exons. Remarkably, upregulated ex-
ons showed on average significantly higher unpaired proba-
bilities at most positions between −25 and −50 than down-
regulated exons while a lower single-strandedness was ob-
served closer to their 3′ss (Figure 3J). This finding suggests
that intramolecular base-pairing interactions over relatively
long distances upstream of 3′ss control exon repression and
activation by U2AF and, most likely, by U2AF-related pro-
teins that showed functional antagonism and synergism
with U2AF and bind single-stranded RNA (Figure 3H).
U2AF(35) preferentially regulates nuclear proteins involved
in RNA binding
Functional enrichment analysis (35) of exons/genes dif-
ferentially used in U2AF35 depleted cells showed that
they were enriched in proteins involved in RNA/nucleotide
binding, respectively (Figure 4A). Figure 4B shows a sin-
gle example of alternative 3′ss in a known RNA-binding
factor SF1. These 3′ss are responsible for production of
BP-binding SF1 proteins with variable C-termini (56) and
are associated with tissue-specific APA sites (Supplemen-
tary Figure S12). These proline-rich regions interact with
PRPF40A (57), a component of the splicesomal E complex
(58). Depletion of U2AF35 was associated with upregula-
tion of SF1 mRNA and promotion of the distal 3′ss (Fig-
ure 4B and C). Transfection of the SF1 splicing reporter
constructs into ab- cells confirmed repression of the proxi-
mal site (Figure 4D and E). Thus, U2AF(35) regulates the
length of SF1 3′UTR and, potentially, its PRPF40A inter-
actions.
In addition to RNA binding, differentially expressed
exons/genes were enriched in proteins involved in cy-
toskeleton organization, chromatin modification and pro-
teins found in the organelle lumen (Figure 4A). Figure 5A
gives a summary of exons in transcripts involved in actin
dynamics. Tropomyosin genes (TPMs), which control func-
tion of actin filaments in a tissue-specific manner (59), serve
as the most prominent examples. In ab- cultures, exon 6a of
TPM1 and TPM2 was repressed and exon 6b, which has a
long PPT in both genes, was activated (Figure 5B). Isoforms
containing exon 6b have lower calcium sensitivity than iso-
forms with exon 6a, which may be required for a specific
interaction with troponin (60). TNNT1, a gene coding for
a slow skeletal muscle troponin T, sustained a cryptic 3′ss
activation upon U2AF35 depletion (data not shown). Be-
sides TPM1/2, exon 9a of TPM3 was upregulated in de-
pleted cells as well as the TPM4 transcripts (Figure 5B and
Supplementary Table S3). TPM3 isoforms expressing exon
9a are more widely distributed in tissues than isoforms con-
taining exon 9c (61), suggesting that U2AF(35) restricts tis-
sue expression of  -tropomyosin.
Finally, Figure 5C shows U2AF(35)-induced alterations
of exon usage in eight genes coding for the histone mod-
ifying SAGA (Spt-Ada-Gcn5 Acetyltransferase) complex
components, including KAT2A and KAT2B. The U2AF35
depletion promoted the use of a distal 5′ss in KAT2A (Sup-
plementary Figure S5F), modifying the balance of alter-
natively spliced GCN5 isoforms and, most likely, histone
acetyltransferase activity. 5′ss selection was influenced also
in a GCN5 paralog KAT2B (PCAF; Supplementary Figure
S5G). The TADA3 gene, which encodes the GCN5 interac-
tion partner, sustained activation of the proximal APA site
upon depletion. In contrast, a proximal APA was repressed
in TAF5L, a component of the SAGA architecture module
(Figure 5D).Activation of proximalAPAwas found also for
TAF9 while a proximal 3′ss was promoted in ATXN7L3, a
component of the deubiquitination module.
Exon-, isoform- and gene-level control of U2AF35 interaction
partners
Over 25% (14/51) genes encoding high-confidence interac-
tion partners of U2AF35 (62) were significantly upregu-
lated or downregulated in depleted cells, which was more
than expected (hypergeometric test, P < 0.05, Table 1).
U2AF2 showed the highest increase, followed by CDC5L,
which encodes a key component of the PRPF19-CDC5L
complex required for the catalytic step of splicing (63).
Upon U2AF35 depletion, the CDC5L interaction part-
ner PLRG1 showed 3′UTR lengthening but CTNNBL1,
CCAP1, CCAP3 and CCAP6 mRNAs were not noticeably
altered. SNRPA1, which binds U2 snRNA (64), had re-
ducedmRNA levels in depleted cultures. Transcripts encod-
ing U2AF35-related protein U2AF26, which can interact
with U2AF65 and functionally substitute U2AF35 in con-
stitutive and enhancer-dependent splicing (65), were also
downregulated while SF3 components SF3B1 and SF3B3
showed alterations in APA selection.
Supplementary Figure S13 shows examples of exon us-
age dependencies of high-confidence U2AF35 interaction
partners. In depleted cells, PTC-containing cryptic exons in
U2AF2 and CAPERα were downregulated and both genes
were upregulated. Expression of CAPER exon 4 was also
increased whilePUF60 exon 5 was downregulated. Alterna-
tive 5′ss of U2AF2 exon 10, which controls the inclusion of
four amino acids in U2AF65, was not altered by U2AF35
depletion and the two U2AF2 isoforms were upregulated
in depleted cells to the same extent (Figure 1F). Together,
these data identify high-confidence interaction partners of
U2AF35 whose expression was altered upon U2AF(35) de-
pletion and reveal exon-centric regulation of closely related
U2AF genes.
Evidence for a distinct function of U2AF35 isoforms
U2AF35a and b differ from each other at seven amino-
acid positions located in the RNP2 motif of the UHM, a
proximal part of a long -helix A and a disordered seg-
ment between the two folded regions (13). Isoform-specific
depletions identified transcripts exhibiting a gradient in
RNA processing defects reflecting total levels of U2AF(35)
but also exons activated only upon ab- depletion where
U2AF levels were the lowest (Supplementary Figures S2
and S3A,B). However, we also found events that occurred
only in b- (Supplementary Figure S14) and a- cultures (Fig-
ure 6A–C), in which the less abundant U2AF1b was in ex-
cess (Figure 1E and Supplementary Figure S3A, lane 6).
They were confirmed in independent transfections using
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Table 1. Gene- and exon-level alterations of high-confidence interaction partners of U2AF35 in ab- cells
Partner gene Gene-levela Exon-level
U2AF2 −1.17 NS
SRSF1 −0.43 Longer 3′UTR as a result of promotion of distal APA
SF3B3 0.54 Longer 3′UTR as a result of promotion of distal APA
SF3B14 −0.65 NS
SF3B1 NS Promotion of distal APA, retention of intron containing proximal APA
CDC5L −0.71 NS
PLRG1 NS Longer 3′UTR as a result of promotion of distal APA
ZCCHC8 −0.51 NS
U2AF26 1.43 NS
SNRPA1 0.97 NS
SAP18 −0.53 NS
SON −0.58 Promotion of putative proximal APA site
MCM5 −0.55 NS
NHP2L1 −0.47 Promotion of proximal alternative transcription initiation site
aNegative log2-fold values indicate upregulation in ab- cells; positive values indicate downregulation. NS, not significantly altered by U2AF35 depletion.
varying siRNA concentrations (Figure 6D) and with exoge-
nous transcripts (Figure 6E and F). For example, U2AF35a
depletion activated a proximal 3′ss of PFN2 intron 2 and
a distal cryptic 5′ss of the same intron whereas U2AF35b
depletion was associated with the opposite effect in a dose-
dependent manner (Figure 6F). The proximal 3′ss was pro-
moted by U2AF35b and repressed by U2AF35a also in re-
constitution experiments in which we individually added
plasmids expressing each isoform to ab- cells (Figure 6G).
Repression and activation of the PFN2 3′ss was confirmed
in cultures depleted with SSOa and SSOb (Supplementary
Figure S1B and data not shown). Alternative 3′ss of PFN2
generate isoforms with distinct C-termini of profilin 2, a key
actin-monomer binding protein, that have distinct binding
affinities for proline-rich sequences and show tissue-specific
expression (66,67). Interestingly, exogenous U2AF35b ex-
pression was higher compared to U2AF35a (Figure 6G).
The existence of isoform-specific effects was also supported
by the number of differentially expressed genes/exons in
isoform-specific depletions, with a significant overlap in
each category and a low ratio of exon-level versus gene-
level events in b- samples (Figure 6H). In contrast to most
transcripts, correlation between U2AF levels and exon us-
age was absent or decreased for genes with isoform-specific
responses (cf. Figure 6I and Supplementary Figure S3).
To reinforce these findings further, we carried out in-
dependent isoform-specific depletion experiments with to-
tal RNA depleted of rRNA. These samples contain a
higher fraction of unprocessed RNA than polyA-selected
RNA, giving more information about intron splicing (68).
DEXSeq analysis followed by browser-assisted verification
revealed that the bias toward start and terminal exons was
even greater than for poly(A) samples and reconfirmed
isoform-specific effects validated experimentally (Supple-
mentary Table S5 and Figure 6 and Supplementary Figure
S14).
Taken together, identification of transcripts with distinct
responses to U2AF35a and U2AF35b argues for the exis-
tence of isoform-specific interactions that may confer even
opposite effects on splice-site selection and provide addi-
tional level of exon regulation.
DISCUSSION
We have shown the first global characterization of RNA
processing alterations associated with depletion ofU2AF35
isoforms. Our data reveal that U2AF function is not lim-
ited to 3′ss recognition but involves extensive APA control
(Figure 2), particularly through intronic APA sites, suggest-
ing that U2AF contributes to the tight regulation of tissue-
specific expression. We have also described characteristic
3′ss organization of U2AF(35)-repressed and -activated ex-
ons and functional antagonism and synergism of U2AF-
related proteins PUF60 and CAPER (Figure 3). The exon
repression and activation was associated with significant
shifts of average unpaired probabilities in their canonical
BP and PPT regions and further upstream. Finally, we de-
scribe exon-centric regulations of genes encoding U2AF35
interaction partners and identify transcripts with distinct
responses to U2AF35a and U2AF35b.
Our results indicate that most but not all changes in
APA and exon usage in cells depleted of U2AF35 were at-
tributable to the lack of U2AF heterodimer (Supplemen-
tary Figure S3 and Figure 6I). They were replicated in cells
lacking U2AF65 (Figure 3H, Supplementary Figures S2
and S11), in agreement with RASL-Seq data submitted
during review of this manuscript and showing significant
overlap of U2AF35- and U2AF65-induced events (69). As
U2AF65 interacts with the 3′ end processing complex, the
association of U2AF with the phosphorylated C-terminal
domain (CTD) of polII and PRPF19 (70,71) could be im-
portant for the U2AF-dependent APA control. U2AF35
depletion was associated with upregulation of CDC5L (Ta-
ble 1), a key component of the PRPF19-CDC5L com-
plex required for promotion of co-transcriptional splic-
ing (72). The impaired balance between post- and co-
transcriptional splicing in cells lacking U2AF is supported
by frequent alterations of weak introns that contained cryp-
tic or alternative exons, often near 3′ gene ends (Sup-
plementary Figures S5C and S13). These ‘detained’ in-
trons are spliced post-transcriptionally in humans (73). In
Drosophila and the mouse, alternative introns are less ef-
ficiently spliced co-transcriptionally than constitutive in-
trons and co-transcriptional splicing is less efficient toward
3′ gene ends than at upstream gene locations (74). The
link between U2AF and transcription and polII elonga-
 at U
niversity of Southam
pton on M
ay 12, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
3760 Nucleic Acids Research, 2015, Vol. 43, No. 7
tion rate (75), which can alter APA choice (76), is further
supported by a biased distribution of differentially used
start and terminal exons in cells depleted of elongation fac-
tors (Supplementary Table S5) and significant overlap of
genes differentially expressed in U2AF35-, hnRNP C- and
AFF4-depleted cells (Supplementary Figure S15). AFF4 is
a key elongation factor while hnRNP C directly competes
with U2AF65 at authentic and cryptic 3′ss (25), in agree-
ment with the observed tendency to antagonize U2AF(35)-
repressed exons (Figure 3H). Altered elongation rates influ-
enced inclusion of ∼15–40% cassette exons on a genome-
wide scale and the slow elongation has been associated with
shorter introns (77), which were prevalent among U2AF-
sensitive events (Supplementary Figure S7).
The APA selection was influenced by U2AF in an APA
category-dependent manner (Figure 2C–E). U2AF appears
to activate proximal APA sites if there is no intron between
competing APA sites and distal APA sites if recognition
of the 5′ss is productive (Figure 2C and D). U2AF65 con-
tacts CFIm59 but not CFIm68 (78), which promoted dis-
tal APA sites (79). PolII CTD also interacts with the CFIm
subunit PCF11 (80) and several splicing factors, including
PRP40, CA150 and PSF (81–83). Significant shifts in cleav-
age site usage, largely toward proximal sites, were observed
for a knockdown of PABPN1 (84), a nuclear protein with
high affinity to poly(A) tails, with 43 genes shared between
PABPN1- and U2AF35-depleted samples (P < 10−8, data
not shown). Finally, U2AF-dependent intronic APA sites
represented the most frequent APA category (Figure 2E),
whereas in normal cells intronic APA sites are less frequent
than tandem 3′UTR and alternative terminal exons (85),
which could be due to widespread binding of U2AF(65) to
introns, with >80% tags in intronic sequences (69).
Similar to other RNA-binding proteins (50,51,86,87),
U2AF(35) can both inhibit and activate splicing (Supple-
mentary Figures S2 and S3). Activated and repressed ex-
ons had a distinct 3′ss organization and functional regula-
tion by Y-binding proteins (Figure 3, Supplementary Fig-
ures S10–S12). The U2AF(35)-repressed exons were largely
stimulated by PUF60 (Supplementary Figure S11A) and in-
hibited by CAPER and also by PTB, in line with longer
AGEZs/PPTs previously found for PTB-repressed cassettes
(50). Because PUF60 preferentially contacts uridines (88),
the PUF60-U2AF antagonism might be explained by com-
petition for binding to uridine-rich sequences. However,
uridine was enriched upstream of both upregulated and
downregulated exons (Supplementary Figure S10) and also
within these exons (Supplementary Figure S7B), arguing
for the importance of adenine/uridine frequency shifts be-
tween optimally located BP and PPT regions (Supplemen-
tary Figure S10A) and between regions showing higher
single-strandedness (Figure 3J). These changes are likely
to alter not only protein binding but also tertiary contacts
and folding transitions by helicases and other RNA chaper-
ones. Structural requirements across 3′ss may also help ex-
plain atypical responses of some transcripts, such asGSK3B
to PUF60 depletion (Supplementary Figure S11A), and
position-dependent alternative splicing activity of a grow-
ing number of proteins and their targets (50,89–91).
PUF60 contains two RNA recognition motifs (RRMs)
and a C-terminal UHM (88). This UHM binds the N-
terminus of SF3b155 at the UHM-ligand motif (ULM)
around W200 (92). The functional PUF60-U2AF antago-
nism might also result from competition of U2AF35 and
PUF60 for the U2AF65 ULM because binding of PUF60
to the U2AF65 ULM can only occur if this motif is
not already bound by the U2AF35 UHM (92). In con-
trast, PUF60 and U2AF65 can bind to the N terminus of
SF3b155 simultaneously and noncompetitively (92). In ad-
dition, U2AF and PUF60 had the opposite effect on BP ac-
cessibility and U2AF was not strictly required for splicing
of some pre-mRNAs in vitrowhen PUF60 was present (51).
Finally, anti-PUF60 antibodies co-precipitated polII CTD
and three components of the general transcription factor
TFIIH (93), linking PUF60 to transcription.Unlike PUF60
on U2AF-repressed exons (Figure 3H), however, slow and
fast polII elongation do not usually have opposite effects on
the inclusion of a given alternative exon (77).
Our study revealed activation and inhibition of many
cryptic exons, both in U2AF-related and unrelated genes.
The elevated U2AF2 mRNA (Figure 1D) can be explained
by repression of a PTC-containing exon in intron 5 in de-
pleted cells (Supplementary Figure S13). This exon is highly
conserved between mouse and man, has a GC 5′ss and is
surrounded by Y-rich sequences. Such cryptic exon activa-
tion appeared to be common in other U2AF35 partners
(Supplementary Figure S13, Table 1). Similar to U2AF2,
CAPERα was upregulated upon U2AF depletion, most
likely through elimination of a PTC-introducing cryptic
exon (Supplementary Figure S13). CAPER showed a
strong synergism with U2AF on upregulated exons (Fig-
ure 3H) and has the same domain structure as U2AF65, ex-
cept for the lack ofULM (94). In contrast, a 48-ntCAPERβ
exon activated in ab- cells (Supplementary Figure S13) does
not present PTCs but is translated only if upstream alter-
native exons are included in the mRNA. The mRNA ex-
pression of PUF60, which lacks both the ULM and the
RS domain (94), was unaffected, although PUF60 exon 5
appeared to respond positively to the excess of U2AF35b
(Supplementary Figure S13). This 51-nt cassette exon intro-
duces extra 17 amino acids close to the first RRMof PUF60
and encodes two serines that are phosphorylated (95).
Although positions −3 and +1 relative to U2AF(35)-
dependent 3′ss may participate in U2AF35-RNA interac-
tions, with binding preferences favoring cytosine at posi-
tion −3 and guanine at position +1 (Supplementary Figure
S4), possibly via ZFs (24), experimental evidence for this
interaction is missing. The higher dependency of weaker
and proximal alternative 3′ss on U2AF35 was finally seen
at the genome-wide level (Supplementary Figure S4, Ta-
ble S9), resolving previous uncertainties (14,24). However,
U2AF(35)-dependent exons and 3′ss were largely alterna-
tively spliced, which makes it difficult to distinguish char-
acteristic sequence features of cassette exons from direct ef-
fects of U2AF35 depletion. For example, alternative splic-
ing and exon skipping was found to correlate positively with
the BP-3′ss distance (41). The distance between 3′ss and the
best predicted BP of exons/3′ss upregulated in ab- cells was
marginally higher than in controls and these 3′ss had also a
higher number of BPs with positive SVM scores (data not
shown). Thus, it remains to be tested how BP choice is af-
fected by a lack of U2AF(35) and by the observed posi-
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tional changes in single-strandedness (Figure 3J). Interest-
ingly, cooperative interactions of U2AF and SF1 increased
the SF1 binding repertoire and SF1 binding was signifi-
cantly biased toward terminal exons (87).
The higher exogenous expression of U2AF35b over
U2AF35a (Figure 6G) and elevated relative abundance of
U2AF35b uponU2AF65 depletion (Supplementary Figure
S3) suggest that interactions of each isoform with U2AF65
could be important for U2AF stability, thus contribut-
ing to tight regulation of U2AF levels in vivo and accu-
rate exon/APA usage. Description of exons with isoform-
specific responses to U2AF35 should facilitate charac-
terization of physical interactions of highly conserved
U2AF35a and U2AF35b isoforms in future studies. These
interactions may involve the extraordinarily long  helix A
(96) and are likely to be affected by post-translational modi-
fications of residues encoded by exon 3/Ab as the size differ-
ence between U2AF35b and U2AF35a appears to be larger
than predicted (Figure 1C and Supplementary Figure S1).
Although U2AF35 is believed to be a 3′ss recognition
factor, we found many examples of 5′ss usage alterations
upon depletion (Supplementary Figure S5). This may be
explained by altered U2AF65-promoted recruitment of U1
snRNP to weak 5′ss (97) but also elongation kinetics of
polII. For example, Rsd1, a yeast homologue of CAPER,
bridges interactions between U1 and U2 snRNPs through
the RS domain of Prp5 (DDX46) (98), which was repressed
in ab- cultures (Supplementary Table S2). Prp5 is required
for a transcription elongation checkpoint and a release of
stalled polII (99). Differentially used alternative 5′ss were
also found in cells lacking other RNA-binding proteins, in-
cluding PTB (50), nevertheless a large excess of U2AF(35)-
dependent 3′ss over 5′ss in our data set is consistent with the
predominant role of this factor in 3′ss recognition.
Finally, genome-wide identification of U2AF(35)-
dependent events and our validation panel will provide
an important resource for more detailed biochemical and
structural studies of 3′ss and APA sites, expanding not
only the number of U2AF35-dependent exons but also
exons sensitive to other factors involved in 3′ss/BP/APA
selection.
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